Home > Medical Reference > Encyclopedia (English)

Toggle: English / Spanish

 

Video details

Do Not Remove This Text

Related Content


 

Membranoproliferative GN II - Treatment

Alternative Names

Membranoproliferative glomerulonephritis (type II); Glomerulonephritis - membranoproliferative (type II); Mesangiocapillary glomerulonephritis (type II); Dense deposit disease; MPGN II

Treatment:

Treatment varies according to the symptoms. The goals of treatment are to reduce symptoms, prevent complications, and slow the worsening of the disorder.

Dietary adjustments may include restrictions on sodium, fluids, protein, or other restrictions to control high blood pressure, swelling, and accumulation of waste products in the bloodstream.

Medicines used to treat this condition and symptoms may include:

  • Blood pressure medications
  • Diuretics

Dialysis or kidney transplantation may eventually be needed to manage renal failure.

Expectations (prognosis):

The disorder progresses slowly to chronic renal failure. Fifty percent of cases will develop chronic renal failure within 10 years.

Calling your health care provider:

Call for an appointment with your health care provider if symptoms indicate MPGN II.

Call for an appointment with your health care provider if symptoms worsen or new symptoms develop, including decreased urine output.

  • Reviewed last on: 8/14/2007
  • Charles Silberberg, DO, Private Practice specializing in Nephrology, Affiliated with New York Medical College, Division of Nephrology, Valhalla, NY. Review provided by VeriMed Healthcare Network.